MyFinsight
Home
Blog
About
ORAMED PHARMACEUTICALS INC. (ORMP)
ORAMED PHARMACEUTICALS INC. (ORMP)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,043K
Free Cash flow
-$202K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Deferred taxes
Proceeds from redemption of shor...
Others
Negative Cash Flow Breakdown
Changes in fair value of investm...
Investment in investment in asso...
Purchase of marketable securitie...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Deferred tax liabilities
-
-9,836
10
-7,688
Other liabilities
0
0
0
0
Net income
78,156
38,310
10,009
48,389
Depreciation
31
30
30
31
Exchange differences and interest on deposits
-267
140
-80
-823
Changes in fair value of investments
103,616
44,851
-158,688
61,163
Stock-based compensation
1,393
1,736
2,284
719
Gain on amounts funded in respect of employee rights upon retirement
3
2
4
2
Prepaid expenses and other current assets
-933
-431
1,261
553
Accounts payable, accrued expenses and related parties
882
149
1,737
2,673
Net changes in operating lease
39
2
32
13
Deferred revenues
0
-2,000
0
0
Deferred income
82
596
-140
245
Liability for employee rights upon retirement
3
1
1
2
Gain on sale of ip
0
5,821
-
-
Deferred taxes
31,633
-
-
-
Total net cash used in operating activities
-200
-2,915
-466
-1,625
Loan to investment in equity method
0
0
0
0
Equity method investee
0
0
-
-
Proceeds from loan to an equity method investee
0
0
0
2,809
Real estate investment
0
0
-204
2,128
Purchase of short-term deposits
-
-
10,948
-
Purchase of non-marketable securities
500
-
-
-
Equity method investee
-
-
250
-
Purchase of marketable securities
8,727
12,861
8,346
1,500
Equity method investee
-
-
-
0
Proceeds from marketable securities
-
2,779
2,865
-
Investments at fair value
-
-999
-395
-746
Proceeds from marketable securities
10,605
-
13,938
24,579
Purchase of convertible note
-
-
3,000
-
Investment at fair value
6,735
-
-
-
Proceeds from redemption of short-term deposits
10,948
0
4,000
18,000
Lifeward transactions
-
11,924
-
-
Investment in investment in associate at fair value- lifeward
11,924
-
-
-
Proceeds from investments
501
-1,077
-
-
Purchase of property and equipment
2
5
2
0
Total net cash used in investing activities
4,310
-19,488
-1,684
38,364
Repurchase and retirement of common stock
0
-
4,009
361
Tax withholdings related to stock-based compensation settlements
1,871
-
-
-
Dividend paid
78
10,364
-
-
Total net cash used in financing activities
-1,949
-10,364
-4,009
-361
Effect of exchange rate changes on cash and cash equivalents
-118
22
-73
4
Decrease in cash and cash equivalents
2,043
-32,745
-6,232
36,382
Cash and cash equivalents at beginning of period
13,202
45,947
52,179
54,420
Cash and cash equivalents at end of period
15,245
13,202
45,947
52,179
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from redemption
of short-term...
$10,948K
(-66.26%↓ Y/Y)
Proceeds from marketable
securities
$10,605K
(910.96%↑ Y/Y)
something is missing
$10,144K
Proceeds from
investments
$501K
(-89.11%↓ Y/Y)
Total net cash used in
investing activities
$4,310K
(113.80%↑ Y/Y)
Canceled cashflow
$27,888K
Decrease in cash and cash
equivalents
$2,043K
(105.29%↑ Y/Y)
Canceled cashflow
$2,267K
Investment in investment in
associate at fair value-...
$11,924K
Purchase of marketable
securities
$8,727K
Investment at fair value
$6,735K
(110.59%↑ Y/Y)
Purchase of
non-marketable securities
$500K
Purchase of property and
equipment
$2K
(-71.43%↓ Y/Y)
Net income
$78,156K
(1291.17%↑ Y/Y)
Deferred taxes
$31,633K
Stock-based compensation
$1,393K
(-53.40%↓ Y/Y)
Prepaid expenses and
other current assets
-$933K
(-14.34%↓ Y/Y)
Accounts payable,
accrued expenses and...
$882K
(126.89%↑ Y/Y)
Exchange differences and
interest on deposits
-$267K
(-465.75%↓ Y/Y)
Net changes in
operating lease
$39K
(-45.83%↓ Y/Y)
Depreciation
$31K
(-48.33%↓ Y/Y)
Liability for employee
rights upon retirement
$3K
(-50.00%↓ Y/Y)
Total net cash used in
financing activities
-$1,949K
(-425.34%↓ Y/Y)
Total net cash used in
operating activities
-$200K
(97.16%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
-$118K
(-402.56%↓ Y/Y)
Canceled cashflow
$113,337K
Tax withholdings
related to stock-based...
$1,871K
Dividend paid
$78K
Changes in fair value of
investments
$103,616K
(806.61%↑ Y/Y)
something is missing
-$9,836K
Deferred income
$82K
(135.19%↑ Y/Y)
Gain on amounts
funded in respect of...
$3K
(-50.00%↓ Y/Y)
Buy us a coffee